日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Elacridar Reverses P-gp-Mediated Drug Resistance in Ovarian Cancer Cells in 2D and 3D Culture Models

在二维和三维培养模型中,Elacridar可逆转卵巢癌细胞中P-gp介导的耐药性

Stasiak, Piotr; Sopel, Justyna; Lipowicz, Julia Maria; Rawłuszko-Wieczorek, Agnieszka Anna; Sterzyńska, Karolina; Korbecki, Jan; Januchowski, Radosław

The Role of Elacridar, a P-gp Inhibitor, in the Re-Sensitization of PAC-Resistant Ovarian Cancer Cell Lines to Cytotoxic Drugs in 2D and 3D Cell Culture Models.

P-gp抑制剂Elacridar在2D和3D细胞培养模型中对PAC耐药卵巢癌细胞系重新敏感化细胞毒性药物的作用

Stasiak Piotr, Sopel Justyna, Lipowicz Julia Maria, Rawłuszko-Wieczorek Agnieszka Anna, Korbecki Jan, Januchowski Radosław

Elacridar Inhibits BCRP Protein Activity in 2D and 3D Cell Culture Models of Ovarian Cancer and Re-Sensitizes Cells to Cytotoxic Drugs.

埃拉克瑞达抑制卵巢癌 2D 和 3D 细胞培养模型中的 BCRP 蛋白活性,并使细胞重新对细胞毒性药物敏感

Stasiak Piotr, Sopel Justyna, Płóciennik Artur, Musielak Oliwia, Lipowicz Julia Maria, Rawłuszko-Wieczorek Agnieszka Anna, Sterzyńska Karolina, Korbecki Jan, Januchowski Radosław

Genes Co-Expressed with ESR2 Influence Clinical Outcomes in Cancer Patients: TCGA Data Analysis

与ESR2共表达的基因影响癌症患者的临床结局:TCGA数据分析

Lipowicz, Julia Maria; Malińska, Agnieszka; Nowicki, Michał; Rawłuszko-Wieczorek, Agnieszka Anna